Clinical Trial Update: A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports completed results for tirzepatide in adults with Type 2 diabetes mellitus, with results posted on 2024-05-20.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2, Hypoglycemia | Phase 1 | Status: COMPLETED | Results posted: 2024-05-20